A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023.
Last Friday, the U.S. Supreme Court announced its decision to grant the government’s petition for certiorari in the Braidwood Management v. Becerra case.
ATLANTA, Ga. – As Georgia lawmakers reconvene for the 2025 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) looks forward to working with them to prioritize legislation to ease the burden of cancer on Georgians.
In proposing to increase Maine’s tax on cigarettes $1 per pack, Governor Mills’ has taken a historic step in the fight to curb tobacco product use among Mainers.
MADISON, Wis. – As Wisconsin lawmakers reconvene for the 2025 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) looks forward to working with them to prioritize legislation to ease the burden of cancer on Wisconsinites.
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.
COLUMBIA, S.C. – As the 2025 legislative session begins Tuesday, the American Cancer Society Cancer Action Network (ACS CAN) urges lawmakers to support policies that will reduce the cancer burden in the Palmetto State.
OLYMPIA, Wash. -- As Washington legislators convene today for a new session, American Cancer Society Cancer Action Network advocates will ask them to prioritize patients' ready access to needed and proven biomarker testing.
A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.